Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.8700
-0.2800 (-24.35%)
At close: Oct 7, 2026, 4:00 PM
0.9300
+0.0600 (6.90%)
After-hours: Oct 7, 2026, 7:49 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $2.95 million as of October 7, 2026. That makes Kairos Pharma the world's 46,886th most valuable company and 6,311th in the United States. Its market cap has decreased by 88.36% in one year.
Market Cap
2.95M
Enterprise Value
319.14K
1-Year Change
-88.36%
Global Rank
Country Rank
#6,311 United States
Category
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $2.95M, a decrease of -91.18%. That is a compound annual growth rate of -69.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 2.95M | -80.08% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cardio Diagnostics Holdings | 6.10M |
| Creative Medical Technology Holdings | 6.07M |
| AIM ImmunoTech | 5.78M |
| Pulmatrix | 5.48M |
| Liminatus Pharma | 5.36M |
| Lunai Bioworks | 5.17M |
| Xenetic Biosciences | 5.13M |
| 60 Degrees Pharmaceuticals | 5.06M |